DSGN - Company ID 0001807120
The table below shows Design Therapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $16.86M | $22.56M | $21.20M | $26.50M | $298.57M |
| Short-term investments | $202.99M | $222.91M | $260.60M | $303.89M | $85.50M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $223.78M | $248.04M | $284.58M | $335.12M | $385.44M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $981.00K | $1.41M | $1.69M | $1.95M | $1.51M |
| Goodwill | - | - | - | - | - |
| Total assets | $226.20M | $252.09M | $289.64M | $341.14M | $390.56M |
| Accounts payable | $2.31M | $2.19M | $1.94M | $3.02M | $1.62M |
| Total current liabilities | $13.05M | $8.46M | $9.62M | $10.78M | $5.28M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $13.70M | $10.00M | $11.96M | $13.83M | $8.43M |
| Retained earnings | -$297.01M | -$227.21M | -$177.63M | -$110.76M | -$47.46M |
| Total equity | $212.50M | $242.10M | $277.69M | $327.31M | $382.13M |